Research workbench
Solution structure of BCL-xl containing the ALPHA1-ALPHA2 disordered loop determined with selective isotope labelling of I,L,V sidechains
Analyse Solution structure of BCL-xl containing the ALPHA1-ALPHA2 disordered loop… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 2ME9
- Type
- protein
- Length
- 212 residues
- Chains
- 1
- Method
- solution nmr
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- BCL-2-like protein 1
- UniProt
- Q07817
- Pockets
- 4 · best druggability 0.59
Structure
solution nmr · 1 distinct chain · 48% helix, 0% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | BCL-2-like protein 1 | protein | 212 | 48% helix, 0% strand | Q07817 |
Pockets
4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 183 | 0.59 | 0.81 | 34 | empty |
| 2 | 77 | 0.46 | 0.81 | 14 | empty |
| 3 | 118 | 0.45 | 0.78 | 18 | empty |
| 4 | 54 | 0.40 | 0.81 | 14 | empty |
Compared structures
- 2ME9 · Solution structure of BCL-xL containing the alpha1-alpha2 disordered loop determined with… · the same entry in another collection · chain A against A, TM-score 1.00
- Q07817 · AlphaFold monomer V2.0 prediction for BCL-2-like protein 1 (Q07817) · a predicted model of the same protein · chain A against A, TM-score 0.56
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q07817
- Elsewhere: RCSB PDB 2ME9 · PDBe 2ME9 · UniProt Q07817
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.